Ocata Therapeutics' IPO

Ocata Therapeutics raised a round of funding on May 14, 2001. Investors include Public.

Ocata Therapeutics (NASDAQ: OCAT), formerly Advanced Cell Technology, is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regene…

Articles about Ocata Therapeutics' IPO: